Search details
1.
The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment.
Immunity
; 49(4): 764-779.e9, 2018 10 16.
Article
in English
| MEDLINE | ID: mdl-30332632
2.
Transcriptional Circuitry of NKX2-1 and SOX1 Defines an Unrecognized Lineage Subtype of Small-Cell Lung Cancer.
Am J Respir Crit Care Med
; 206(12): 1480-1494, 2022 12 15.
Article
in English
| MEDLINE | ID: mdl-35848993
3.
Foxa2 and Cdx2 cooperate with Nkx2-1 to inhibit lung adenocarcinoma metastasis.
Genes Dev
; 29(17): 1850-62, 2015 Sep 01.
Article
in English
| MEDLINE | ID: mdl-26341558
4.
SnapShot: Lung cancer models.
Cell
; 149(1): 246-246.e1, 2012 Mar 30.
Article
in English
| MEDLINE | ID: mdl-22464334
5.
Reciprocal regulation of pancreatic ductal adenocarcinoma growth and molecular subtype by HNF4α and SIX1/4.
Gut
; 70(5): 900-914, 2021 05.
Article
in English
| MEDLINE | ID: mdl-32826305
6.
Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma.
Mol Cell
; 50(2): 185-99, 2013 Apr 25.
Article
in English
| MEDLINE | ID: mdl-23523371
7.
Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target.
Genes Dev
; 27(2): 197-210, 2013 Jan 15.
Article
in English
| MEDLINE | ID: mdl-23322301
8.
Nuclear factor I/B is an oncogene in small cell lung cancer.
Genes Dev
; 25(14): 1470-5, 2011 Jul 15.
Article
in English
| MEDLINE | ID: mdl-21764851
9.
Suppression of lung adenocarcinoma progression by Nkx2-1.
Nature
; 473(7345): 101-4, 2011 May 05.
Article
in English
| MEDLINE | ID: mdl-21471965
10.
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas.
J Pathol
; 234(2): 190-202, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-24852265
11.
Aberrant AKT activation drives well-differentiated liposarcoma.
Proc Natl Acad Sci U S A
; 108(39): 16386-91, 2011 Sep 27.
Article
in English
| MEDLINE | ID: mdl-21930930
12.
Inhibition of ULK1/2 and KRAS G12C controls tumor growth in preclinical models of lung cancer.
bioRxiv
; 2024 Feb 08.
Article
in English
| MEDLINE | ID: mdl-38370808
13.
FoxA1/2-dependent epigenomic reprogramming drives lineage switching in lung adenocarcinoma.
bioRxiv
; 2023 Nov 02.
Article
in English
| MEDLINE | ID: mdl-37961260
14.
NKX2-1 controls lung cancer progression by inducing DUSP6 to dampen ERK activity.
Oncogene
; 41(2): 293-300, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34689179
15.
FoxA1 and FoxA2 control growth and cellular identity in NKX2-1-positive lung adenocarcinoma.
Dev Cell
; 57(15): 1866-1882.e10, 2022 08 08.
Article
in English
| MEDLINE | ID: mdl-35835117
16.
Cell type-specific DNA methylation patterns in the human breast.
Proc Natl Acad Sci U S A
; 105(37): 14076-81, 2008 Sep 16.
Article
in English
| MEDLINE | ID: mdl-18780791
17.
An NKX2-1/ERK/WNT feedback loop modulates gastric identity and response to targeted therapy in lung adenocarcinoma.
Elife
; 102021 04 06.
Article
in English
| MEDLINE | ID: mdl-33821796
18.
c-Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme.
J Pathol
; 218(3): 292-300, 2009 Jul.
Article
in English
| MEDLINE | ID: mdl-19449367
19.
Identification of CD44v6(+)/CD24- breast carcinoma cells in primary human tumors by quantum dot-conjugated antibodies.
Lab Invest
; 89(8): 857-66, 2009 Aug.
Article
in English
| MEDLINE | ID: mdl-19488035
20.
Publisher Correction: Protective autophagy elicited by RAFâMEKâERK inhibition suggests a treatment strategy for RAS-driven cancers.
Nat Med
; 25(5): 861, 2019 May.
Article
in English
| MEDLINE | ID: mdl-30918364